News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
29,258 Results
Type
Article (3163)
Company Profile (4)
Press Release (26091)
Section
Business (8919)
Career Advice (66)
Deals (1417)
Drug Delivery (15)
Drug Development (3239)
Employer Resources (19)
FDA (857)
Job Trends (1025)
News (14831)
Policy (1959)
Tag
Academia (101)
Adcomms (2)
Allergies (2)
Alliances (1857)
Alzheimer's disease (68)
Antibody-drug conjugate (ADC) (13)
Approvals (868)
Artificial intelligence (14)
Autoimmune disease (2)
Automation (1)
Bankruptcy (20)
Best Places to Work (796)
BIOSECURE Act (5)
Biosimilars (24)
Biotechnology (1)
Bladder cancer (12)
Breast cancer (2)
Cancer (126)
Cardiovascular disease (9)
Career advice (61)
Career pathing (3)
CAR-T (28)
Cell therapy (52)
Cervical cancer (5)
Clinical research (2533)
Collaboration (26)
Compensation (5)
Complete response letters (1)
COVID-19 (384)
C-suite (25)
Data (105)
Denatured (3)
Depression (12)
Diabetes (9)
Diagnostics (298)
Digital health (2)
Diversity (3)
Diversity, equity & inclusion (5)
Drug discovery (7)
Drug pricing (32)
Duchenne muscular dystrophy (4)
Earnings (1702)
Editorial (6)
Employer branding (7)
Employer resources (17)
Events (3936)
Executive appointments (108)
FDA (932)
Featured Employer (1)
Funding (53)
Gene editing (1)
Generative AI (3)
Gene therapy (10)
GLP-1 (51)
Government (367)
Healthcare (1014)
Immunology and inflammation (17)
Indications (5)
Infectious disease (392)
Inflammatory bowel disease (15)
Inflation Reduction Act (2)
Influenza (2)
Intellectual property (3)
Interviews (5)
IPO (433)
IRA (21)
Job creations (276)
Job search strategy (58)
Labor market (3)
Layoffs (34)
Legal (696)
Liver cancer (4)
Lung cancer (44)
Lymphoma (6)
Machine learning (1)
Management (4)
Manufacturing (19)
Medical device (1139)
Medtech (1141)
Mergers & acquisitions (1017)
Metabolic disorders (21)
Multiple sclerosis (2)
NASH (1)
Neurodegenerative disease (7)
Neuropsychiatric disorders (7)
Neuroscience (104)
NextGen: Class of 2025 (362)
Non-profit (229)
Northern California (82)
Obesity (13)
Opinion (26)
Pain (4)
Parkinson's disease (15)
Partnered (2)
Patents (15)
Patient recruitment (5)
Peanut (2)
People (4742)
Pharmaceutical (3)
Pharmacy benefit managers (5)
Phase I (586)
Phase II (867)
Phase III (1381)
Pipeline (56)
Podcasts (9)
Policy (34)
Postmarket research (186)
Preclinical (189)
Press Release (2)
Prostate cancer (5)
Psychedelics (5)
Radiopharmaceuticals (9)
Rare diseases (12)
Real estate (245)
Recruiting (7)
Regulatory (1052)
Reports (4)
Research institute (106)
Resumes & cover letters (4)
RSV (1)
Schizophrenia (8)
Series A (13)
Series B (5)
Service/supplier (1)
Sickle cell disease (1)
Southern California (90)
Special edition (6)
Spinal muscular atrophy (1)
Startups (313)
Tariffs (4)
The Weekly (6)
United States (885)
Vaccines (102)
Venture capitalists (4)
Webinars (1)
Weight loss (10)
Women's health (4)
Date
Today (8)
Last 7 days (36)
Last 30 days (148)
Last 365 days (1684)
2025 (441)
2024 (1747)
2023 (1765)
2022 (2954)
2021 (3194)
2020 (2823)
2019 (2117)
2018 (1625)
2017 (1488)
2016 (1447)
2015 (1509)
2014 (1050)
2013 (898)
2012 (922)
2011 (868)
2010 (724)
Location
Africa (57)
Arizona (14)
Arkansas (1)
Asia (1430)
Australia (279)
California (216)
Canada (49)
China (24)
Colorado (5)
Connecticut (12)
Delaware (10)
Europe (4235)
Florida (33)
Georgia (4)
Idaho (3)
Illinois (28)
India (4)
Indiana (14)
Iowa (1)
Japan (8)
Kansas (3)
Kentucky (1)
Louisiana (1)
Maine (1)
Maryland (41)
Massachusetts (104)
Michigan (10)
Minnesota (25)
Mississippi (1)
Missouri (1)
Nebraska (1)
Nevada (2)
New Hampshire (4)
New Jersey (118)
New Mexico (1)
New York (48)
North Carolina (26)
Northern California (82)
Ohio (8)
Pennsylvania (70)
South America (63)
Southern California (90)
Tennessee (12)
Texas (46)
Utah (7)
Virginia (1)
Washington D.C. (10)
Washington State (19)
Wisconsin (2)
29,258 Results for "johnson medtech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025
March 11, 2025
·
14 min read
Business
James Brodie of Johnson & Johnson MedTech Appointed Chair of the Medtech Canada Board of Directors
Medtech Canada is very pleased to welcome James Brodie of Johnson & Johnson MedTech as Chair of the Medtech Canada Board of Directors.
May 10, 2024
·
3 min read
Press Releases
Johnson & Johnson MedTech Announces CE Mark Approval for Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter
January 10, 2025
·
10 min read
Press Releases
Johnson & Johnson MedTech Receives IDE Approval for OTTAVA™ Robotic Surgical System
November 13, 2024
·
6 min read
Press Releases
Johnson & Johnson MedTech Launches VOLT™ Plating System
October 10, 2024
·
8 min read
Press Releases
Johnson & Johnson MedTech Receives FDA Approval for the VARIPULSE™ Pulsed Field Ablation Platform for the Treatment of Atrial Fibrillation
November 7, 2024
·
10 min read
Deals
Johnson & Johnson Completes Acquisition of Shockwave Medical
Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson & Johnson MedTech.
May 31, 2024
·
5 min read
Press Releases
Johnson & Johnson Announces Expected Closing Date for Intra-Cellular Acquisition
April 2, 2025
·
4 min read
Deals
Johnson & Johnson MedTech Acquires Laminar, Inc.
Johnson & Johnson MedTech 1 today announced the completion of the acquisition 2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib).
November 30, 2023
·
7 min read
Press Releases
Johnson & Johnson Announces Darren Snellgrove as Vice President, Investor Relations
March 5, 2025
·
2 min read
1 of 2,926
Next
